We will test a new approach to management of malignant pleural effusions (MPE) based on chemotherapintrapleural administration of AD 32 rather than pleurodesis. There are about 100,000 cases p.a. ofca ...SBIR Phase I 1995 Department of Health and Human Services
Anthra Pharmaceuticals, Inc.
| 174 Tamarack Circle
Skillman, NJ, 08558
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|